These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31318157)

  • 1. Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease.
    Tang A; Branscomb J; Zhou M; Snyder A; Eckman J
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27921. PubMed ID: 31318157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
    Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events of red blood cell transfusions in patients with sickle cell disease.
    Rollins MR; Chou ST
    Transfus Apher Sci; 2022 Oct; 61(5):103557. PubMed ID: 36064527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
    Pirenne F; Yazdanbakhsh K
    Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
    Chou ST; Fasano RM
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
    Mercure-Corriveau N; Crowe EP; Vozniak S; Feng X; Rai H; Van Denakker T; Zakieh A; Grabowski MK; Lanzkron S; Tobian AAR; Bloch EM
    Transfusion; 2024 Jan; 64(1):124-131. PubMed ID: 38069526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of transfusion practices in sickle cell disease in Senegal: cohort study of 1078 patients with sickle cell disease.
    Seck M; Tall A; Faye BF; Bah DS; Guéye Y; Sall A; Touré AO; Diop S
    Med Sante Trop; 2017 Nov; 27(4):402-406. PubMed ID: 29313508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for transfusion in the management of sickle cell disease.
    Han H; Hensch L; Tubman VN
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):696-703. PubMed ID: 34889416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I manage red cell transfusions in patients with sickle cell disease.
    Rees DC; Robinson S; Howard J
    Br J Haematol; 2018 Feb; 180(4):607-617. PubMed ID: 29377071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.
    Winkler AM; Josephson CD
    Immunohematology; 2012; 28(1):24-6. PubMed ID: 22646147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.